>>9038738 (pb)

2018 Mar;70(3):481-485. doi: 10.1002/acr.23296. Epub 2018 Feb 9.

Abstract

OBJECTIVE:

Some sources urge caution when prescribing hydroxychloroquine (HCQ) to patients with G6PDH deficiency, presumably due to a risk of hemolytic anemia. There are limited published data, however, to support this risk. Additionally, not all patients with G6PDH deficiency are at similar risk for hemolysis, and people with the African variant are at particularly low risk.

https://www.ncbi.nlm.nih.gov/pubmed/28556555